Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–10. doi:10.3322/caac.21551.
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura SI. Carcinoma of the colon and rectum. In: Bosman F, Carneiro F, Hruban R, Theise N, et al., editors. WHO classification of tumours of the digestive system. Lyon, France: IARC Press; 2010. p. 134–146.
   Google Scholar
• McMillan DC. The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.003.
   PubMed Web of Science ®Google Scholar
• Park JH, Watt DG, Roxburgh CSD, Horgan PG, McMillan DC. Colorectal cancer, systemic inflammation, and outcome. Ann Surg. 2016;263(2):326–336. doi:10.1097/SLA.0000000000001122.
   PubMed Web of Science ®Google Scholar
• Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, Langner C. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol. 2010;41(12):1749–1757. doi:10.1016/j.humpath.2010.04.018.
   PubMed Web of Science ®Google Scholar
• Komori K, Kanemitsu Y, Kimura K, Hattori N, Sano T, Ito S, Abe T, Senda Y, Misawa K, Ito Y, et al. Tumor necrosis in patients with TNM stage IV colorectal cancer without residual disease (R0 Status) is associated with a poor prognosis. Anticancer Res. 2013;33(3):1099–1105.
   PubMed Web of Science ®Google Scholar
• Väyrynen SA, Väyrynen JP, Klintrup K, Mäkelä J, Karttunen TJ, Tuomisto A, Mäkinen MJ. Clinical impact and network of determinants of tumour necrosis in colorectal cancer. Br J Cancer. 2016;114(12):1334–1342. doi:10.1038/bjc.2016.128.
   PubMed Web of Science ®Google Scholar
• Kantola T, Klintrup K, Väyrynen JP, Vornanen J, Bloigu R, Karhu T, Herzig K-H, Näpänkangas J, Mäkelä J, Karttunen TJ, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 2012;107(10):1729–1736. doi:10.1038/bjc.2012.456.
   PubMed Web of Science ®Google Scholar
• Argilés JM, Stemmler B, López-Soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol. 2019;15(1):9–20. doi:10.1038/s41574-018-0123-0.
   Web of Science ®Google Scholar
• Guthrie GJK, Roxburgh CSD, Richards CH, Horgan PG, McMillan DC. Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer. 2013;109(1):131–137. doi:10.1038/bjc.2013.291.
   PubMed Web of Science ®Google Scholar
• Ueno T, Toi M, Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother. 2005;59(Suppl 2):S359–S362. doi:10.1016/S0753-3322(05)80078-2.
   PubMed Web of Science ®Google Scholar
• Omary MB, Ku N-O, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest. 2009;119(7):1794–1805. doi:10.1172/JCI37762.
   PubMed Web of Science ®Google Scholar
• Caulín C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol. 1997;138(6):1379–1394. doi:10.1083/jcb.138.6.1379.
   PubMed Web of Science ®Google Scholar
• Schutte B, Henfling M, Kölgen W, Bouman M, Meex S, Leers MP, Nap M, Björklund V, Björklund P, Björklund B, et al. Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res. 2004;297(1):11–26. doi:10.1016/j.yexcr.2004.02.019.
   PubMed Web of Science ®Google Scholar
• Kramer G, Erdal H, Mertens HJMM, Nap M, Mauermann J, Steiner G, Marberger M, Bivén K, Shoshan MC, Linder S. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004;64(5):1751–1756. doi:10.1158/0008-5472.CAN-03-2455.
   PubMed Web of Science ®Google Scholar
• Ozturk B, Coskun U, Sancak B, Yaman E, Buyukberber S, Benekli M. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. Int Immunopharmacol. 2009;9(5):645–648. doi:10.1016/j.intimp.2009.02.004.
   PubMed Web of Science ®Google Scholar
• Ulukaya E, Yilmaztepe A, Akgoz S, Linder S, Karadag M. The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival. Lung Cancer. 2007;56(3):399–404. doi:10.1016/j.lungcan.2007.01.015.
   PubMed Web of Science ®Google Scholar
• Yaman E, Coskun U, Sancak B, Buyukberber S, Ozturk B, Benekli M. Serum M30 levels are associated with survival in advanced gastric carcinoma patients. Int Immunopharmacol. 2010;10(7):719–722. doi:10.1016/j.intimp.2010.03.013.
   PubMed Web of Science ®Google Scholar
• Scott LC, Evans TRJ, Cassidy J, Harden S, Paul J, Ullah R, O’Brien V, Brown R. Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response. Br J Cancer. 2009;101(3):410–417. doi:10.1038/sj.bjc.6605175.
   PubMed Web of Science ®Google Scholar
• Greystoke A, Dean E, Saunders MP, Cummings J, Hughes A, Ranson M, Dive C, Renehan AG. Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer. Br J Cancer. 2012;107(9):1518–1524. doi:10.1038/bjc.2012.416.
   PubMed Web of Science ®Google Scholar
• Oven Ustaalioglu B, Bilici A, Ercan S, Orcun A, Seker M, Ozkan A, Ustaalioglu R, Gumus M. Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls. Clin Transl Oncol. 2012;14(5):356–361. doi:10.1007/s12094-012-0808-0.
   PubMed Web of Science ®Google Scholar
• Koelink PJ, Lamers CB, Hommes DW, Verspaget HW. Circulating cell death products predict clinical outcome of colorectal cancer patients. BMC Cancer. 2009;9(1):88. doi:10.1186/1471-2407-9-88.
   PubMed Web of Science ®Google Scholar
• Dive C, Smith RA, Garner E, Ward T, George-Smith SS, Campbell F, Greenhalf W, Ghaneh P, Neoptolemos JP. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br J Cancer. 2010;102(3):577–582. doi:10.1038/sj.bjc.6605494.
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Tuomisto A, Väyrynen SA, Klintrup K, Karhu T, Mäkelä J, Herzig K-H, Karttunen TJ, Mäkinen MJ. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival. Sci Rep. 2018;8(1):1126. doi:10.1038/s41598-018-19572-y.
   PubMed Web of Science ®Google Scholar
• Moilanen JM, Kokkonen N, Löffek S, Väyrynen JP, Syväniemi E, Hurskainen T, Mäkinen M, Klintrup K, Mäkelä J, Sormunen R, et al. Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. Hum Pathol. 2015;46(3):434–442. doi:10.1016/j.humpath.2014.11.020.
   PubMed Web of Science ®Google Scholar
• Kantola T, Väyrynen JP, Klintrup K, Mäkelä J, Karppinen SM, Pihlajaniemi T, Autio-Harmainen H, Karttunen TJ, Mäkinen MJ, Tuomisto A. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. Br J Cancer. 2014;111(8):1605–1613. doi:10.1038/bjc.2014.456.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93:387–391. doi:10.1038/sj.bjc.6602678.
   PubMed Web of Science ®Google Scholar
• Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ. Inflammation and prognosis in colorectal cancer. Eur J Cancer. 2005;41(17):2645–2654. doi:10.1016/j.ejca.2005.07.017.
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer. 2013;109(7):1839–1847. doi:10.1038/bjc.2013.508.
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Sajanti SA, Klintrup K, Mäkelä J, Herzig K-H, Karttunen TJ, Tuomisto A, Mäkinen MJ. Characteristics and significance of colorectal cancer associated lymphoid reaction. Int J Cancer. 2014;134(9):2126–2135. doi:10.1002/ijc.28533.
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Vornanen JO, Sajanti S, Böhm JP, Tuomisto A, Mäkinen MJ. An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Arch. 2012;460(5):455–465. doi:10.1007/s00428-012-1232-0.
   PubMed Web of Science ®Google Scholar
• Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with image. J Biophotonics Int. 2004;11:36–42.
   Google Scholar
• Väyrynen JP, Vornanen J, Tervahartiala T, Sorsa T, Bloigu R, Salo T, Tuomisto A, Mäkinen MJ. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer. 2012;131(4):E463–E474. doi:10.1002/ijc.26435.
   PubMed Web of Science ®Google Scholar
• Sajanti SA, Väyrynen JP, Sirniö P, Klintrup K, Mäkelä J, Tuomisto A, Mäkinen MJ. Annexin A10 is a marker for the serrated pathway of colorectal carcinoma. Virchows Arch. 2015;466(1):5–12. doi:10.1007/s00428-014-1683-6.
   PubMed Web of Science ®Google Scholar
• Sajanti SA, Sirniö P, Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Ristimäki A, Mäkinen MJ. VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma. Virchows Arch. 2014;464. doi:10.1007/s00428-014-1555-0.
   Web of Science ®Google Scholar
• McMillan DC, Crozier JEM, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22(8):881–886. doi:10.1007/s00384-006-0259-6.
   PubMed Web of Science ®Google Scholar
• Tuomisto AE, Mäkinen MJ, Väyrynen JP. Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25:4383–4404. doi:10.3748/wjg.v25.i31.4383.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16(8):717–727. doi:10.1038/ncb3015.
   PubMed Web of Science ®Google Scholar
• Richards CH, Roxburgh CSD, Anderson JH, McKee RF, Foulis AK, Horgan PG, McMillan DC. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg. 2012;99(2):287–294. doi:10.1002/bjs.7755.
   PubMed Web of Science ®Google Scholar
• Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129(6):705–733. doi:10.1007/s00418-008-0435-6.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther. 2009;30(11–12):1103–1109. doi:10.1111/j.1365-2036.2009.04148.x.
   PubMed Web of Science ®Google Scholar
• Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, Leclercq S, Van Hul M, Plovier H, Pachikian B, et al. Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. Oncotarget. 2018;9(26):18224–18238. doi:10.18632/oncotarget.24804.
   PubMedGoogle Scholar
• Puppa MJ, White JP, Sato S, Cairns M, Baynes JW, Carson JA. Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexia. Biochim Biophys Acta – Mol Basis Dis. 2011;1812(12):1601–1606. doi:10.1016/j.bbadis.2011.08.010.
   PubMed Web of Science ®Google Scholar
• Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol. 2012;3:56. doi:10.3389/fphys.2012.00056.
   PubMed Web of Science ®Google Scholar
• Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735–6741. doi:10.1158/1078-0432.CCR-07-4843.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107. doi:10.1038/nature08780.
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Kantola T, Väyrynen SA, Klintrup K, Bloigu R, Karhu T, Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A, et al. The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer. Int J Cancer. 2016;139. doi:10.1002/ijc.30040.
   Web of Science ®Google Scholar
• Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7(1):16717. doi:10.1038/s41598-017-16955-5.
   PubMed Web of Science ®Google Scholar